Clinical Trial Update: DLBS2411 Treatment For Functional Dyspepsia [Phase 3]

View source ↗

Summary

Phase 3 trial of DLBS2411 for functional dyspepsia has completed. The update confirms the study status but does not report results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Functional Dyspepsia

Drugs mentioned

• DLBS2411

Snippet

Sponsor: Dexa Medica Group | Conditions: Functional Dyspepsia | Phase 3 | Status: COMPLETED